Physician profile
Michael Kunkel
NPI 1689677825
$4,823.17
in general payments reported to CMS, 2019-2025
36 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $138 · 2022: $294 · 2023: $874 · 2024: $1,010 · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,385.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $642.77 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $572.35 | 2019-2025 | |
| Abbvie INC. | $506.87 | 2019-2025 | |
| Lilly USA, LLC | $369.06 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $287.18 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Otsuka America Pharmaceutical, INC. | $259.57 | 2023-2025 | Rexulti |
| Amgen INC. | $257.05 | 2019-2024 | Otezla, Repatha, Prolia |
| Glaxosmithkline, LLC. | $256.59 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $225.59 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $184.56 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.48 | 2019-2024 | Synjardy, Tradjenta, Jardiance |
| Dexcom, INC. | $134.04 | 2022-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $119.88 | 2019 | |
| Abbott Laboratories | $97.81 | 2024-2025 | |
| Amarin Pharma, INC. | $73.98 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $73.47 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $65.68 | 2024-2025 | Impella |
| Exact Sciences Corporation | $63.71 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.86 | 2019-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $52.41 | 2019-2025 | Eliquis, Camzyos |
| Astellas Pharma US INC | $47.15 | 2019-2025 | Veozah |
| Merck Sharp & Dohme LLC | $44.30 | 2019-2025 | Capvaxive |
| Xeris Pharmaceuticals, INC. | $36.09 | 2024 | Gvoke Hypopen |
| Scilex Pharmaceuticals INC. | $34.91 | 2019 | |
| Phathom Pharmaceuticals, INC. | $27.93 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $25.34 | 2019 | |
| Daiichi Sankyo INC. | $24.45 | 2022 | |
| Boston Scientific Corporation | $20.55 | 2025 | Watchman Flx |
| Inspire Medical Systems, INC. | $19.70 | 2025 | Inspire |
| Hikma Pharmaceuticals USA | $18.90 | 2019 | |
| Medtronic, INC. | $18.40 | 2025 | Intellis Adaptivestim |
| Insmed, INC. | $14.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.86 | 2019 | |
| Allergan, INC. | $12.89 | 2020 | |
| Sanofi Pasteur INC. | $12.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kunkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.